Travere Therapeutics (TVTX)

• Market cap: $3.13B
• 1 day: 3.1%
• 5 days: 7.18%
• 1 month: 33.66%
• 3 months: 91.66%
• 6 months: 65.67%
• Year to date: 84.19%
• 1 year: 89.17%
• 5 years: 44.92%
• 10 years: 90.2%
• Sector: Healthcare
• Industry: Biotechnology

About: Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Employees: 385